SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-017133
Filing Date
2020-07-09
Accepted
2020-07-09 21:17:51
Documents
1
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7149
  Complete submission text file 0001213900-20-017133.txt   8527
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Issuer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address
Shabahang Shahrokh (Reporting) CIK: 0001816754 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39336 | Film No.: 201021600